The Fight Isn't Over 👊

Debbie Churgai of Americans for Safe Access talks about the difficulties medical cannabis companies and patients face.‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Why Medical Cannabis Advocates Are Still Battling Matthew Carr | Chief Trends Strategist | The Oxford Club   Have You Heard About the "Billionaire's Launch Pad"? Most people don't know this... But what we call the "Billionaire's Launch Pad" is one of the REAL ways wealthy people like Jeff Bezos, Bill Gates, Mark Zuckerberg and others have made their fortunes. A video has just surfaced on the internet, revealing this launch pad. Click here to watch it now.   Editor's Note: At one point in his life, Matthew Carr had only $0.51 in his pocket. And now that he's a millionaire, he's offering spots in his Rags-to-Riches Masterclass for the same price! The reason is... he wants to make this class available to anyone who wants to change their situation. Even if you're starting from the bottom like he did. Don't miss out on the opportunity to turn your life around! Click here now. - Assistant Managing Editor, Kaitlyn Hopkins     In 1996, Californians cast their ballots for Proposition 215. This legalized medical marijuana in the state. Over the next handful of years, Alaska, Colorado, the District of Columbia, Hawaii, Maine, Nevada, Oregon and Washington followed suit. And that momentum didn't die down. Today, 33 states have legalized medical cannabis. Roughly 60% of Americans live in a state that allows legal access to medical marijuana. But there's still plenty of work to be done. To discuss this, I'm joined today by Americans for Safe Access (ASA) interim director, Debbie Churgai. For nearly two decades, the nonprofit has been a champion for patient rights and consumer safety, and has strived to remove cannabis as a Schedule I drug. For the medical marijuana industry, the current infrastructure in the U.S. provides several challenges. And Churgai delves into the difficulties medical marijuana companies - and patients - face. We explore marijuana's role in fighting the opioid crisis, as well as the Food and Drug Administration's view that more CBD research needs to be done. She also explains why cannabis advocacy continues to be imperative, particularly in today's rapidly changing world. Medical marijuana is a segment of the market I think investors shouldn't ignore. This interview tackles some of the obstacles the industry currently faces - you don't want to miss this! Here's to high returns, Matthew       Lower Battery Costs Mean More Affordable EVs David Fessler | January 29, 2020 Better technology, combined with rising demand, is driving down battery costs to make EVs more affordable. Read More   How to Book Gains Amid the Coronavirus Outbreak Matthew Carr | January 28, 2020 The Wuhan coronavirus is the latest outbreak weighing on investors' minds​.​ Here's how to profit from it. Read More   Marijuana's March Madness Matthew Carr | January 27, 2020 Marijuana sales historically decline from October through February, but then spring to life, sparking March Madness. Read More   The $1.1 Million Mistake (That Could Make YOU Rich!) Marc Lichtenfeld just made an innocent keyboard error on his supercomputer... and it unlocked a hidden gold mine in the stock market that you've likely NEVER seen before...Check out the crazy story behind Marc's discovery right here.     You are receiving this email because you subscribed to Profit Trends. To unsubscribe from Profit Trends, click here. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Profit Trends | Attn: Member Services | 105 West Monument Street | Baltimore, MD 21201 North America: 1.800.589.3430 | International: +1.443.353.4334 | Fax: 1.410.329.1923 Website: profittrends.com Keep the emails you value from falling into your spam folder. Whitelist Profit Trends. © 2020 The Oxford Club LLC All Rights Reserved   The Oxford Club is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. Members should be aware that although our track record is highly rated by an independent analysis and has been legally reviewed, investment markets have inherent risks and there can be no guarantee of future profits. The stated returns may also include option trades. We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of printed-only publications prior to following an initial recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, 105 W. Monument Street, Baltimore MD 21201.